Sign in
4/A

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-13-000516

Options or other derivatives

  • Chief Technical Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bazan J. Fernando · Chief Technical Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-08-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +10,000 $76.02 2020-07-31 10,000 10,000 D
2013-08-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +15,000 $76.02 2020-07-31 15,000 15,000 D
Loading xslF345X03/edgar.xml…